Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
Mass vaccination against coronavirus disease 2019 (COVID-19) is a global health strategy to control the COVID-19 pandemic. With the increasing number of vaccinations, COVID-19 vaccine-associated lymphadenopathy (C19-VAL) has been frequently reported. Current findings emphasize the characteristics of...
Main Authors: | Tzu-Chuan Ho, Daniel Hueng-Yuan Shen, Chin-Chuan Chang, Hung-Pin Chan, Kuo-Pin Chuang, Cheng-Hui Yuan, Ciao-Ning Chen, Ming-Hui Yang, Yu-Chang Tyan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/3/696 |
Similar Items
-
COVID-19 vaccine associated axillary lymphadenopathy – A systematic review
by: Michael Co, et al.
Published: (2022-01-01) -
Management Outcomes of Lymphadenopathy among the Children
by: Siamand Yahya Salim ,, et al.
Published: (2023-12-01) -
A ten-year histopathological study of generalised lymphadenopathy in India
by: G.C. Kamat
Published: (2011-07-01) -
Causes and Presentation Of Cervical Lymphadenopathy
by: Arifullah Bangash, et al.
Published: (2018-03-01) -
Difficulties of differential diagnosis of lymphadenopathy in acute brucellosis (clinical cases)
by: Nikita A. Tereshkin, et al.
Published: (2023-04-01)